Nano Dimension Q2: A $40.4M Goodwill Impairment, Material Weakness, and a Board Overhaul
NNDM sits 29% above its 52-week low of $1.19 on light trading volume (0.3× avg).
Summary
Nano Dimension reported a $40.4M goodwill impairment and a material weakness in internal controls, alongside a board and CEO overhaul following a settlement with activist Murchinson.
Key Events · Earnings and Guidance · NNDM
-
Goodwill Impairment
A $40.4 million impairment charge was taken on the Markforged FFF product line goodwill, reducing the goodwill balance to zero.
-
Material Weakness Disclosed
Management concluded that internal controls over financial reporting were not effective due to insufficient resources with appropriate accounting knowledge for business combinations and discontinued operations.
-
Q2 Financial Results
Revenue rose 12% to $29.0 million, gross profit nearly doubled to $13.3 million, but the net loss from continuing operations was $6.8 million.
-
Board and CEO Overhaul
Subsequent to quarter-end, a settlement with Murchinson led to the resignation of four directors, appointment of three new directors, and the naming of an interim CEO.
Analysis · NNDM · Manufacturing
Investors face a critical update as Nano Dimension's Q2 2026 results reveal a $40.4 million goodwill impairment tied to the Markforged FFF product line, which wiped out the remaining goodwill balance. The company also disclosed a material weakness in internal controls, citing insufficient resources to properly account for business combinations and discontinued operations. While revenue grew 12% to $29 million, the net loss from continuing operations reached $6.8 million. Subsequent to quarter-end, the company settled with activist Murchinson, replaced four directors, appointed an interim CEO, and terminated its headquarters lease for $13 million. The convergence of a large impairment, a control weakness, and a board overhaul demands attention.
At the time of this filing, NNDM was trading at $1.53 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $326.5M. The 52-week trading range was $1.19 to $2.32. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.